| EP0594729 - 2-(4-HYDROXYPIPERIDINO)-1-ALKANOL DERIVATIVES AS ANTIISCHEMIC AGENTS [Right-click to bookmark this link] | Status | The application has been refused Status updated on 10.11.2000 Database last updated on 28.03.2026 | Most recent event Tooltip | 10.11.2000 | Refusal of application | published on 27.12.2000 [2000/52] | Applicant(s) | For all designated states Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US | [N/P] |
| Former [1994/18] | For all designated states PFIZER INC. 235 East 42nd Street New York, N.Y. 10017 / US | Inventor(s) | 01 /
WELCH, Willard, McKowan, Jr. 116 Pequot Avenue Mystic, CT 06355 / US | [1994/18] | Representative(s) | Moore, James William, et al Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ / GB | [N/P] |
| Former [1994/18] | Moore, James William, Dr., et al Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ / GB | Application number, filing date | 92915510.9 | 19.06.1992 | [1994/18] | WO1992US04973 | Priority number, date | US19910731577 | 17.07.1991 Original published format: US 731577 | [1994/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9302052 | Date: | 04.02.1993 | Language: | EN | [1993/04] | Type: | A1 Application with search report | No.: | EP0594729 | Date: | 04.05.1994 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.02.1993 takes the place of the publication of the European patent application. | [1994/18] | Search report(s) | International search report - published on: | EP | 04.02.1993 | Classification | IPC: | C07D211/48, C07D211/44, C07D401/06, A61K31/445 | [1994/18] | CPC: |
C07D401/06 (EP);
A61P25/00 (EP);
A61P25/28 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE [1994/18] | Title | German: | 2-(4-HYDROXYPIPERIDINO)-1-ALKANOLDERIVATE ALS ANTI-ISCHÄMISCHE WIRKSTOFFE | [1994/18] | English: | 2-(4-HYDROXYPIPERIDINO)-1-ALKANOL DERIVATIVES AS ANTIISCHEMIC AGENTS | [1994/18] | French: | DERIVES 2-(4-HYDROXYPIPERIDINO)-1-ALCANOL UTILISES COMME AGENTS ANTI-ISCHEMIQUES | [1994/18] | Entry into regional phase | 10.01.1994 | National basic fee paid | 10.01.1994 | Designation fee(s) paid | 10.01.1994 | Examination fee paid | Examination procedure | 09.11.1992 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 10.01.1994 | Examination requested [1994/18] | 29.07.1994 | Despatch of a communication from the examining division (Time limit: M04) | 25.10.1994 | Reply to a communication from the examining division | 03.09.1996 | Despatch of a communication from the examining division (Time limit: M04) | 12.11.1996 | Reply to a communication from the examining division | 30.03.1999 | Despatch of a communication from the examining division (Time limit: M04) | 14.05.1999 | Reply to a communication from the examining division | 25.02.2000 | Despatch of communication of intention to grant (Approval: ) | 03.08.2000 | Despatch of communication that the application is refused, reason: formalities examination [2000/52] | 13.08.2000 | Application refused, date of legal effect [2000/52] | Fees paid | Renewal fee | 19.04.1994 | Renewal fee patent year 03 | 16.03.1995 | Renewal fee patent year 04 | 27.03.1996 | Renewal fee patent year 05 | 10.04.1997 | Renewal fee patent year 06 | 09.04.1998 | Renewal fee patent year 07 | 10.04.1999 | Renewal fee patent year 08 | 10.03.2000 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||